Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 23.7B | 21.9B | 22.5B | 22.5B |
Cost of revenue | 7.6B | 7.4B | 7.1B | 7.0B |
Gross profit | 16.1B | 14.5B | 15.4B | 15.5B |
Operating expense | ||||
Research & development | 3.5B | 3.2B | 5.3B | 5.0B |
Selling general and admin | 5.8B | 5.0B | 6.3B | 5.3B |
Other operating expenses | — | — | — | — |
Operating income | 6.8B | 6.3B | 3.8B | 5.3B |
Non operating interest income | ||||
Income | 260M | 332M | 281M | 292M |
Expense | 308M | 204M | 137M | 193M |
Other income expense | -264M | 7.2B | -59M | -2.0B |
Pretax income | 6.5B | 13.6B | 3.9B | 3.3B |
Tax provision | 954M | 2.6B | 456M | 644M |
Net income | 5.5B | 11.0B | 3.4B | 2.7B |
Basic EPS | 2.3 | 4.6 | 1.4 | 1.1 |
Diluted EPS | 2.3 | 4.5 | 1.4 | 1.1 |
Basic average shares | 2.4B | 2.4B | 2.4B | 2.4B |
Diluted average shares | 2.4B | 2.4B | 2.4B | 2.4B |
EBITDA | 9.2B | 8.7B | 6.0B | 7.9B |
Net income from continuing op. | 5.5B | 11.0B | 3.4B | 2.7B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |